세계의 임상시험용 포장 시장 : 예측(2025-2030년)

The Global Clinical Trials Packaging Market is expected to grow from USD 2.740 billion in 2025 to USD 4.139 billion in 2030, at a CAGR of 8.60%.

The Global Clinical Trials Packaging Market study provides a comprehensive analysis of the packaging solutions tailored for clinical trials, addressing the needs of pharmaceutical and biotechnology companies worldwide. This study is designed for industry experts seeking in-depth insights into market dynamics, technological advancements, and competitive strategies shaping this specialized sector. Covering product types, material types, packaging types, and geographic regions, the study offers a detailed examination of market trends and opportunities, with a particular focus on recent developments in the competitive landscape.

Market Overview and Scope

The Global Clinical Trials Packaging Market study explores the critical role of packaging in ensuring the integrity, safety, and compliance of clinical trial materials. It defines the market as encompassing packaging solutions such as vials, blisters, tubes, bottles, sachets, bags, pouches, and other formats, segmented by material (plastic, glass, metal, paper & paperboard, and others) and packaging type (primary, secondary, and tertiary). The analysis spans key regions, including North America, South America, Europe, Middle East and Africa, and Asia Pacific, providing granular insights into regional market dynamics and country-specific trends. The study also evaluates market drivers, such as increasing clinical trial activities, and restraints, including stringent regulatory requirements, to offer a balanced perspective on growth potential.

Competitive Environment and Analysis

In the Global Clinical Trials Packaging Market, the competitive environment is marked by strategic innovations and collaborations among key players. This section highlights significant developments from major market participants, focusing on their efforts to strengthen market positions and address evolving industry demands. Below are two notable developments from key players:

• Piramal Pharma Solutions: Piramal Pharma Solutions has recently expanded its clinical trial packaging capabilities through strategic investments in advanced packaging technologies. In 2024, the company introduced a new line of smart packaging solutions integrated with IoT-enabled tracking systems. These solutions enhance real-time monitoring of clinical trial materials, ensuring temperature control and tamper-evidence during transportation. This development aligns with the growing demand for secure and compliant packaging in global clinical trials, particularly for biologics and temperature-sensitive therapies. Piramal's focus on technology-driven packaging positions it as a leader in addressing regulatory and logistical challenges, strengthening its competitive edge in the market.
• Thermo Fisher Scientific Inc.: Thermo Fisher Scientific has made significant strides in sustainable packaging for clinical trials, launching a range of eco-friendly packaging solutions in 2025. These include biodegradable pouches and recyclable secondary packaging designed to meet environmental regulations while maintaining product integrity. This initiative responds to increasing pressure from regulatory bodies and clients to adopt sustainable practices in clinical trial supply chains. By integrating sustainability into its packaging portfolio, Thermo Fisher not only addresses environmental concerns but also appeals to pharmaceutical companies prioritizing green initiatives, enhancing its market share in the Global Clinical Trials Packaging Market.

These developments reflect broader trends in the competitive landscape, where innovation in smart and sustainable packaging solutions is becoming a key differentiator. The study's competitive analysis also includes market share evaluations, mergers, acquisitions, and collaborations, providing a holistic view of how major players like Almac Group, Clinigen Clinical Supplies Management, and PCI Services are navigating the market. The competitive dashboard offers a visual representation of these dynamics, enabling industry experts to assess strategic positioning and market influence.

Strategic and Technological Insights

The Global Clinical Trials Packaging Market study delves into technological advancements shaping the industry, such as the adoption of smart packaging and automation in packaging processes. These innovations enhance efficiency, reduce errors, and ensure compliance with stringent regulations, which are critical in clinical trial logistics. The study also includes a Porter's Five Forces analysis to evaluate competitive intensity and an industry value chain analysis to highlight key stakeholders' roles, from raw material suppliers to packaging service providers. Strategic recommendations are provided to help companies capitalize on emerging opportunities, such as expanding into high-growth regions like Asia Pacific or investing in sustainable packaging solutions.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2022 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation:

By Product Type

• Vials
• Blisters
• Tubes
• Bottles
• Sachets
• Bags and Pouches
• Others

By Material Type

• Plastic
• Glass
• Metal
• Paper & Paperboard
• Others

By Packaging Type

• Primary Packaging
• Secondary Packaging
• Tertiary Packaging

By Geography

• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• UK
• Germany
• France
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• Japan
• China
• India
• South Korea
• Indonesia
• Taiwan
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL CLINICAL TRIALS PACKAGING MARKET BY PRODUCT TYPE

• 5.1. Introduction
• 5.2. Vials
• 5.3. Blisters
• 5.4. Tubes
• 5.5. Bottles
• 5.6. Sachets
• 5.7. Bags and Pouches
• 5.8. Others

6. GLOBAL CLINICAL TRIALS PACKAGING MARKET BY MATERIAL TYPE

• 6.1. Introduction
• 6.2. Plastic
• 6.3. Glass
• 6.4. Metal
• 6.5. Paper & Paperboard
• 6.6. Others

7. GLOBAL CLINICAL TRIALS PACKAGING MARKET BY PACKAGING TYPE

• 7.1. Introduction
• 7.2. Primary Packaging
• 7.3. Secondary Packaging
• 7.4. Tertiary Packaging

8. GLOBAL CLINICAL TRIALS PACKAGING MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. By Product Type
  • 8.2.2. By Material Type
  • 8.2.3. By Packaging Type
  • 8.2.4. By Country
    • 8.2.4.1. USA
    • 8.2.4.2. Canada
    • 8.2.4.3. Mexico
• 8.3. South America
  • 8.3.1. By Product Type
  • 8.3.2. By Material Type
  • 8.3.3. By Packaging Type
  • 8.3.4. By Country
    • 8.3.4.1. Brazil
    • 8.3.4.2. Argentina
    • 8.3.4.3. Others
• 8.4. Europe
  • 8.4.1. By Product Type
  • 8.4.2. By Material Type
  • 8.4.3. By Packaging Type
  • 8.4.4. By Country
    • 8.4.4.1. United Kingdom
    • 8.4.4.2. Germany
    • 8.4.4.3. France
    • 8.4.4.4. Spain
    • 8.4.4.5. Others
• 8.5. Middle East and Africa
  • 8.5.1. By Product Type
  • 8.5.2. By Material Type
  • 8.5.3. By Packaging Type
  • 8.5.4. By Country
    • 8.5.4.1. Saudi Arabia
    • 8.5.4.2. UAE
    • 8.5.4.3. Others
• 8.6. Asia Pacific
  • 8.6.1. By Product Type
  • 8.6.2. By Material Type
  • 8.6.3. By Packaging Type
  • 8.6.4. By Country
    • 8.6.4.1. China
    • 8.6.4.2. Japan
    • 8.6.4.3. India
    • 8.6.4.4. South Korea
    • 8.6.4.5. Taiwan
    • 8.6.4.6. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. Piramal Pharma Solutions
• 10.2. Almac Group
• 10.3. Thermo Fisher Scientific Inc.
• 10.4. Clinigen Clinical Supplies Management
• 10.5. Xerimis
• 10.6. PCI Services
• 10.7. SGS SA (Quay Pharma)
• 10.8. Bilcare Ltd
• 10.9. Lonza
• 10.10. Mikart, LLC

11. APPENDIX

• 11.1. Currency
• 11.2. Assumptions
• 11.3. Base and Forecast Years Timeline
• 11.4. Key benefits for the stakeholders
• 11.5. Research Methodology
• 11.6. Abbreviations